BAL PHARMA
|
The Current P/S Ratio of BAL PHARMA is 0.40.
| Share Price | ₹83.4 | Aug 26,2026 |
| Market Cap | ₹132.6 Cr | |
| Sales-TTM | ₹334.4 Cr | TTM-Consolidated Results |
| Price/Sales | 0.40x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹132.6 Cr] as on Aug 26,2026
(/) Sales [ ₹334.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.40x ]
Thus, for BAL PHARMA , the investors are currently willing to pay '0.40 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAL PHARMA !
The chart below summarizes the trend in P/S Ratio of BAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BAL PHARMA
PS Ratio Performance Analysis for BAL PHARMA
- BAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.42x.
- BAL PHARMA 's operated at median p/e ratio of 0.43x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2022 at 0.57x.
- BAL PHARMA 's p/e ratio hit its five-year low in Mar2021 of 0.32x.
How does BAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BAL PHARMA | 334.4 | 0.40 | 132.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.61 | 456,114.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.31 | 239,321.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.82 | 185,924.0 |
| CIPLA LTD | 28,324.4 | 4.02 | 113,778.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.98 | 99,025.9 |
| MANKIND PHARMA LTD | 14,737.9 | 6.71 | 98,829.9 |
| LUPIN LTD | 29,966.6 | 3.34 | 100,196.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.00 | 114,508.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.67 | 93,326.3 |
| LAURUS LABS LTD | 7,269.6 | 14.03 | 102,011.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAL PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.40x |
| Max industry PS | 21.31x |
| Median industry PS | 4.02x |
| Average industry PS | 7.17x |
You may also like the below Video Courses